*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Prevalence of Depression Among People Living with HIV/AIDS and Comparative Efficacy of Escitalopram Versus Agomelatine in HIV-Positive Patients with Depression in Kanpur, India

Author: DR PUSHPENDRA PUSHKAR, DR VIRENDRA KUSHWAHA, DR RANJIT KUMAR NIM, DR POOJA AGRAWAL, DR DHANANJAY CHAUDHARY, DR AMIT KUMAR, DR HIMANSHU SHARMA
Abstract: Objectives: The objective of this study was to assess the prevalence of depression and the changes in depression symptoms following agomelatine and escitalopram drug therapy in HIV-positive patients suffering from mild to moderate depression. Methods: This was a prospective observational study in which HIV-positive patients on antiretroviral therapy reporting to the ART centre were screened for depression as per the International Classification of Diseases. The enrolled patients were randomly allocated into two groups to receive either agomelatine (25 mg/day) or escitalopram (10 mg/day). Depression severity was assessed using the HAMD scale at Day-0 and each follow-up visit. Results: 194 HIV-positive patients on ART were screened, out of which 56 (28.87%) patients were found to be suffering from depression. Out of 56 patients, 36 (64.28%), 17 (30.36%) and 3 (5.36%) patients were suffering from mild, moderate and severe depression, respectively. Out of 49 patients enrolled, 40 completed the study. The change from baseline to subsequent visits within-group HAMD scores was clinically relevant and statistically significant (p <0.0001) in both groups of patients. There was a statistically significant difference in the betweengroup HAMD scores, with a greater reduction in score with escitalopram than with agomelatine. Conclusions: The prevalence of depression among PLHA is substantial and highlight the grim need to include mental health care including routine screening and treatment for mental disorders to optimize patient care, improve quality of life and health outcomes. Escitalopram showed significantly higher efficacy than agomelatine considering the early response and better relief from symptoms of depression
Keyword: Depression, HIV/AIDS, Prevalence, Escitalopram, Agomelatine
DOI: https://doi.org/10.31838/ijpr/2021.13.03.007
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free